Page last updated: 2024-08-26

equol and B16 Melanoma

equol has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kamachi, S; Komatsu, S; Kumazoe, M; Lin, I; Murata, M; Oka, C; Tachibana, H; Yamashita, S1

Other Studies

1 other study(ies) available for equol and B16 Melanoma

ArticleYear
Soy isoflavone metabolite equol inhibits cancer cell proliferation in a PAP associated domain containing 5-dependent and an estrogen receptor-independent manner.
    The Journal of nutritional biochemistry, 2022, Volume: 100

    Topics: Cell Line, Tumor; Cell Proliferation; Equol; Estrogen Receptor alpha; HeLa Cells; Humans; Isoflavones; MCF-7 Cells; Melanoma, Experimental; MicroRNAs; Neoplasm Transplantation; Receptors, Estrogen; RNA Nucleotidyltransferases; RNA, Small Nucleolar

2022